Cowen Prime Advisors LLC Cytosorbents Corp Transaction History
Cowen Prime Advisors LLC
- $287 Million
- Q2 2023
A detailed history of Cowen Prime Advisors LLC transactions in Cytosorbents Corp stock. As of the latest transaction made, Cowen Prime Advisors LLC holds 42,301 shares of CTSO stock, worth $36,378. This represents 0.05% of its overall portfolio holdings.
Number of Shares
42,301
Previous 46,050
8.14%
Holding current value
$36,378
Previous $113,000
33.63%
% of portfolio
0.05%
Previous 0.05%
Shares
9 transactions
Others Institutions Holding CTSO
# of Institutions
53Shares Held
17.8MCall Options Held
0Put Options Held
0-
Avenir Corp Washington, DC3.17MShares$2.73 Million0.27% of portfolio
-
Granahan Investment Management, LLC Waltham, MA3.04MShares$2.62 Million0.1% of portfolio
-
Skylands Capital, LLC2.88MShares$2.47 Million0.4% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.95MShares$1.68 Million0.0% of portfolio
-
Neuberger Berman Group LLC New York, NY1.91MShares$1.64 Million0.0% of portfolio
About Cytosorbents Corp
- Ticker CTSO
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 43,577,400
- Market Cap $37.5M
- Description
- Cytosorbents Corporation engages in the research, development, and commercialization of medical devices with its blood purification technology platform incorporating a proprietary adsorbent and porous polymer technology. Its flagship product is CytoSorb, an extracorporeal cytokine filter for adjunctive therapy in the treatment of sepsis, adjunct...